Skip to content

ASND

Ascendis Pharma A/S

NASDAQ · DKHealthcareBiotechnology
$260.00-0.38%

Price as of Jul 20, 2026

ASND ownership

Ascendis Pharma A/S ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
4/100
Buys (3m)
5
Sells (3m)
1
Net (3m)
-$4.4M
Insiders buyingCluster buying
Insider trades by month Buys Sells
May
Jun
Context3-month price +15.1%Institutions mixed (13F)
DateInsiderTypeSharesPrice
Jun 2, 2026SMITH SCOTT THOMASofficer: EVP & Chief Financial OfficerBuy100$219.00
Jun 1, 2026BIENAIME JEAN JACQUESdirectorBuy200$223.76
Jun 1, 2026BIENAIME JEAN JACQUESdirectorBuy100$223.50
Jun 1, 2026SMITH SCOTT THOMASofficer: EVP & Chief Financial OfficerBuy250$223.32
May 27, 2026BIENAIME JEAN JACQUESdirectorBuy200$236.24
May 12, 2026JENSEN FLEMMING STEENofficer: See RemarksSell19,460$238.49

Source: ASND SEC Form 4 filings, latest Jun 2, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their ASND positions over the last 6 months (SEC Form 13F).

Increased
229
New positions
92
Reduced
196
Sold out
123
Largest moves
InstitutionActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Unchanged10.3MMay 15, 2026
RA CAPITAL MANAGEMENT, L.P.Unchanged10.3MFeb 17, 2026
WESTFIELD CAPITAL MANAGEMENT CO LPReduced5.2MFeb 11, 2026
AVORO CAPITAL ADVISORS LLCIncreased5.1MMar 16, 2026
AVORO CAPITAL ADVISORS LLCReduced5.1MMay 15, 2026
WESTFIELD CAPITAL MANAGEMENT CO LPReduced4.8MMay 11, 2026
FMR LLCReduced4.2MFeb 17, 2026
JANUS HENDERSON GROUP PLCReduced4.1MFeb 17, 2026
FMR LLCReduced3.9MMay 15, 2026
ARTISAN PARTNERS LIMITED PARTNERSHIPIncreased3.2MMay 13, 2026
ARTISAN PARTNERS LIMITED PARTNERSHIPReduced3.2MFeb 17, 2026
CAPITAL INTERNATIONAL INVESTORSIncreased3.1MFeb 11, 2026
FRANKLIN RESOURCES INCIncreased2.1MMay 13, 2026
CAPITAL INTERNATIONAL INVESTORSReduced2.0MMay 13, 2026
FRANKLIN RESOURCES INCIncreased1.9MFeb 11, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.